1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Neurotoxins Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Neurotoxins Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. Europe Neurotoxins Market Regional Analysis
6.1 Europe Neurotoxins Market Overview
6.2 Europe Neurotoxins Market Revenue 2021-2028 (US$ Million)
6.3 Europe Neurotoxins Market Forecast Analysis
7. Europe Neurotoxins Market Analysis – by Product Type
7.1 Botox
- 7.1.1 Overview
- 7.1.2 Botox: Europe Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Dysport
- 7.2.1 Overview
- 7.2.2 Dysport: Europe Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Xenomin
- 7.3.1 Overview
- 7.3.2 Xenomin: Europe Neurotoxins Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Neurotoxins Market Analysis – by Application
8.1 Therapeutic and Aesthetic
- 8.1.1 Overview
- 8.1.2 Therapeutic and Aesthetic: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Neurotoxins Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Therapeutic and Aesthetic: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Therapeutic and Aesthetic: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Dermatology Clinics
- 9.3.1 Overview
- 9.3.2 Therapeutic and Aesthetic: Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Neurotoxins Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Neurotoxins Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.1.1.1 Europe Neurotoxins Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Neurotoxins Market Breakdown, by Product Type
- 10.1.1.1.2 UK: Europe Neurotoxins Market Breakdown, by Application
- 10.1.1.1.3 UK: Europe Neurotoxins Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Neurotoxins Market Breakdown, by Product Type
- 10.1.1.2.2 Germany: Europe Neurotoxins Market Breakdown, by Application
- 10.1.1.2.3 Germany: Europe Neurotoxins Market Breakdown, by End User
- 10.1.1.3 France:
Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Neurotoxins Market Breakdown, by Product Type
- 10.1.1.3.2 France: Europe Neurotoxins Market Breakdown, by Application
- 10.1.1.3.3 France: Europe Neurotoxins Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Neurotoxins Market Breakdown, by Product Type
- 10.1.1.4.2 Russia: Europe Neurotoxins Market Breakdown, by Application
- 10.1.1.4.3 Russia: Europe Neurotoxins Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Neurotoxins Market Breakdown, by Product Type
- 10.1.1.5.2 Italy: Europe Neurotoxins Market Breakdown, by Application
- 10.1.1.5.3 Italy: Europe Neurotoxins Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Neurotoxins Market Breakdown, by Product Type
- 10.1.1.6.2 Rest of Europe: Europe Neurotoxins Market Breakdown, by Application
- 10.1.1.6.3 Rest of Europe: Europe Neurotoxins Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Neurotoxins Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 AbbVie Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Evolus Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Hugel Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Ipsen SA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Medytox Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merz Pharma GmbH & Co KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights